Cite
HARVARD Citation
Liu, J. et al. (2016). GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease. Cancer letters. 376 (1), pp. 104-109. [Online].